Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
MCKESSON CORP
Insider Francisco Fraga of McKesson Corp reported changes in beneficial ownership of securities as of October 15, 2026. This filing serves as a standard Form 4 disclosure regarding insider stock transactions.…more
MCKESSON CORP
McKesson Corp executive Francisco Fraga has filed a Form 144 regarding the proposed sale of company securities. This filing serves as a standard notification of an insider's plan to dispose of shares.…more
MCKESSON CORP
McKesson Corporation has entered into a definitive agreement with CD&R to acquire Option Care Health for $32.05 per share, representing a total enterprise value of approximately $5.8 billion. McKesson will invest approximately $1.4 billion to acquire a 49% minority interest, with the transaction expected to close in the first half of 2027. This acquisition is part of McKesson's strategy to expand its specialty care capabilities and enhance access to complex therapies.…more
22 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
CD&R and McKesson to Acquire Option Care Health for $5.8 Billion
CD&R and McKesson have entered a definitive agreement to acquire Option Care Health for $32.05 per share, valuing the company at approximately $5.8 billion. Option Care Health will continue to operate as a separate entity under its existing management team.…more
●●●●●●●● ●●●●● ●●●●●●
Cardinal Health and McKesson have extended their pharmaceutical distribution agreements with CVS Health until 2032, securing long-term revenue stability. Both companies reaffirmed their existing fiscal 2027 earnings guidance, signaling continued operational confidence.…more
●●●●●●●● ●●●●● ●●●●●●
McKesson has reaffirmed its fiscal year 2027 adjusted EPS guidance range of $44.20 to $45.00. The company also maintained its long-term adjusted EPS growth rate projection of 13% to 16%.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.